145 related articles for article (PubMed ID: 22753208)
1. Optimal antihypertensive level for improvement of coronary microvascular dysfunction: the lower, the better?
Mizuno R; Fujimoto S; Saito Y; Okamoto Y
Hypertension; 2012 Aug; 60(2):326-32. PubMed ID: 22753208
[TBL] [Abstract][Full Text] [Related]
2. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function.
Erdogan D; Yildirim I; Ciftci O; Ozer I; Caliskan M; Gullu H; Muderrisoglu H
Circulation; 2007 Feb; 115(5):593-9. PubMed ID: 17283278
[TBL] [Abstract][Full Text] [Related]
3. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension.
Eftekhari A; Mathiassen ON; Buus NH; Gotzsche O; Mulvany MJ; Christensen KL
J Hypertens; 2012 Apr; 30(4):794-801. PubMed ID: 22306851
[TBL] [Abstract][Full Text] [Related]
4. Relation of coronary flow reserve and diastolic function to fractional pulse pressure in hypertensive patients.
Mahfouz RA
Echocardiography; 2013 Oct; 30(9):1084-90. PubMed ID: 23659386
[TBL] [Abstract][Full Text] [Related]
5. Increased morning blood pressure surge and coronary microvascular dysfunction in patient with early stage hypertension.
Caliskan M; Caliskan Z; Gullu H; Keles N; Bulur S; Turan Y; Kostek O; Ciftci O; Guven A; Aung SM; Muderrisoglu H
J Am Soc Hypertens; 2014 Sep; 8(9):652-9. PubMed ID: 25224866
[TBL] [Abstract][Full Text] [Related]
6. Impact of uncontrolled blood pressure on diagnostic accuracy of coronary flow reserve for detecting significant coronary stenosis in hypertensive patients.
Li WH; Xu WX; Li ZP; Li CP; Wang XY; He LY; Zhao W; Feng XH; Gao W
Chin Med J (Engl); 2013 Mar; 126(5):839-44. PubMed ID: 23489787
[TBL] [Abstract][Full Text] [Related]
7. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
8. [Impact of blood pressure control on coronary flow reserve in hypertensive patients].
Du LF; Li ZP; Li D; Li WH; Ren C; Ma QB; Gao W
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 May; 44(5):421-5. PubMed ID: 27220578
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hypertension: lower is better, or is it?
Bavry AA; Pepine CJ
Hypertension; 2012 Aug; 60(2):281-2. PubMed ID: 22753207
[No Abstract] [Full Text] [Related]
10. Effect of rosuvastatin on coronary flow reserve in patients with systemic hypertension.
Sun BJ; Hwang E; Jang JY; Kim DH; Song JM; Kang DH
Am J Cardiol; 2014 Oct; 114(8):1234-7. PubMed ID: 25159238
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
[TBL] [Abstract][Full Text] [Related]
13. Investigation of skin vasoreactivity and blood flow oscillations in hypertensive patients: effect of short-term antihypertensive treatment.
Rossi M; Bradbury A; Magagna A; Pesce M; Taddei S; Stefanovska A
J Hypertens; 2011 Aug; 29(8):1569-76. PubMed ID: 21720275
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan improves coronary flow reserve of hypertensive patients using coronary magnetic resonance imaging compared with amlodipine.
Toyama T; Sato C; Koyama K; Kasama S; Murakami J; Yamashita E; Kawaguchi R; Adachi H; Hoshizaki H; Oshima S
Cardiology; 2012; 122(4):230-6. PubMed ID: 22906847
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reducing effects of Phalaris canariensis in normotensive and spontaneously hypertensive rats.
Passos CS; Carvalho LN; Pontes RB; Campos RR; Ikuta O; Boim MA
Can J Physiol Pharmacol; 2012 Feb; 90(2):201-8. PubMed ID: 22309003
[TBL] [Abstract][Full Text] [Related]
16. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
[TBL] [Abstract][Full Text] [Related]
17. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.
Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C;
J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011
[TBL] [Abstract][Full Text] [Related]
18. Effect of candesartan on coronary flow reserve in patients with systemic hypertension.
Tomás JP; Moya JL; Barrios V; Campuzano R; Guzman G; Megías A; Ruiz-Leria S; Catalán P; Marfil T; Tarancón B; Muriel A; García-Lledó A
J Hypertens; 2006 Oct; 24(10):2109-14. PubMed ID: 16957573
[TBL] [Abstract][Full Text] [Related]
19. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease.
Tona F; Serra R; Di Ascenzo L; Osto E; Scarda A; Fabris R; Montisci R; Famoso G; Tellatin S; Foletto M; Giovagnoni A; Iliceto S; Vettor R
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):447-53. PubMed ID: 24548662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
